A versatile technique for the in vivo imaging of human tumor xenografts using near-infrared fluorochrome-conjugated macromolecule probes

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Suemizu, Hiroshi ^a   Kawai, Kenji ^a   Higuchi, Yuichiro ^a   Hashimoto, Haruo ^a   Ogura, Tomoyuki ^a   Itoh, Toshio ^a   Sasaki, Erika ^a   Nakamura, Masato ^a,b  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; FLUOROCHROME; HLA ANTIGEN; IMMUNOGLOBULIN G2A; PROTEIN TDTOMATO; RED FLUORESCENT PROTEIN; UNCLASSIFIED DRUG; XENOLIGHT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MOUSE; NEAR INFRARED FLUOROCHROME CONJUGATED MACROMOLECULE PROBE; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; PANCREAS CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR DIAGNOSIS; TUMOR XENOGRAFT; WHOLE BODY IMAGING; XENOTRANSPLANTATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FLUORESCENT DYES; HCT116 CELLS; HETEROGRAFTS; HUMANS; MOLECULAR IMAGING; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED;

EID: 84893137537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082708     Document Type: Article

References (30)

1. Chang CJ, Tai KF, Roffler S, Hwang LH (2004) The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors. J Immunol 173: 6025-6032.
2. Giavazzi R, Campbell DE, Jessup JM, Cleary K, Fidler IJ (1986) Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res 46: 1928-1933.
3. Suemizu H, Monnai M, Ohnishi Y, Ito M, Tamaoki N, et al. (2007) Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. Int J Oncol 31: 741-751.
4. Hamada K, Monnai M, Kawai K, Nishime C, Kito C, et al. (2008) Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. Int J Oncol 32: 153-159.
5. Bibby MC (2004) Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40: 852-857.
6. Troy T, Jekic-McMullen D, Sambucetti L, Rice B (2004) Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging 3: 9-23.
7. Deliolanis NC, Kasmieh R, Wurdinger T, Tannous BA, Shah K, et al. (2008) Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. J Biomed Opt 13: 044008.
8. Lin MZ, McKeown MR, Ng HL, Aguilera TA, Shaner NC, et al. (2009) Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. Chem Biol 16: 1169-1179.
9. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46: 6387-6392.
10. Greish K, Fang J, Inutsuka T, Nagamitsu A, Maeda H (2003) Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. Clin Pharmacokinet 42: 1089-1105.
11. Keereweer S, Mol IM, Kerrebijn JD, Van Driel PB, Xie B, et al. (2012) Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer. J Surg Oncol 105: 714-718.
12. Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Garrido F (1991) Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol 2: 47-54.
13. Machida K, Suemizu H, Kawai K, Ishikawa T, Sawada R, et al. (2009) Higher susceptibility of NOG mice to xenotransplanted tumors. J Toxicol Sci 34: 123-127.
14. Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnai M, et al. (2011) The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 405: 405-410.
15. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, et al. (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107.
16. Isaacson JH, Cattanach BM (1962) Mouse News Letter 27: 31.
17. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. (2002) NOD/ SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
18. Oshika Y, Nakamura M, Abe Y, Fukuchi Y, Yoshimura M, et al. (1998) Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF). Eur J Cancer 34: 1958-1961.
19. Moro M, Bertolini G, Tortoreto M, Pastorino U, Sozzi G, et al. (2012) Patient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells. J Biomed Biotechnol 2012: 568567.
20. Hoffman R (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359.
21. Yang M, Baranov E, Jiang P, Sun FX, Li XM, et al. (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci U S A 97: 1206-1211.
22. Bouvet M, Yang M, Nardin S, Wang X, Jiang P, et al. (2000) Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models. Clin Exp Metastasis 18: 213-218.
23. Luo S, Zhang E, Su Y, Cheng T, Shi C (2011) A review of NIR dyes in cancer targeting and imaging. Biomaterials 32: 7127-7138.
24. Zhang X, Bloch S, Akers W, Achilefu S (2012) Near-infrared molecular probes for in vivo imaging. Curr Protoc Cytom Chapter 12: Unit12 27.
25. Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, et al. (2009) Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 324: 804-807.
26. Filonov GS, Piatkevich KD, Ting LM, Zhang J, Kim K, et al. (2011) Bright and stable near-infrared fluorescent protein for in vivo imaging. Nat Biotechnol 29: 757-761.
27. Maeda H, Bharate GY, Daruwalla J (2009) Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 71: 409-419.
28. Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, et al. (1998) Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 103: 335-342.
29. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, et al. (2008) Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 99: 1462-1467.
30. Vora AR, Rodgers S, Parker AJ, Start R, Rees RC, et al. (1997) An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. Br J Cancer 76: 836-844.